NPI registry status
Active
2026 NPPES data Addiction Medicine (Internal Medicine) Physician NPI 1205928355 M.D.
Verify on CMS → Daniel Gaskin, Jr., M.D.
Addiction Medicine (Internal Medicine) Physician in Savannah, Georgia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 571 in Addiction Medicine (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 118 beneficiaries · Addiction Medicine (Internal Medicine) Physician avg: 1K
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$37.7
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Daniel Gaskin, Jr., M.D. filed 1,589 Medicare Part D claims in 2024 as an Addiction Medicine (Internal Medicine) Physician in Savannah, Georgia, prescribing 94% generic.
- 2K
- Part D claims, 2024
- 94%
- generic prescribing
- $37.7
- industry payments (Sunshine Act)
- ≥81st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Daniel Gaskin, Jr., M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1205928355), first enumerated 09/28/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,589 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$37.7 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1205928355 · Addiction Medicine (Internal Medicine) Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-MID · BOOK-THIN · PHOTO-ENUM
- NPI-10 1205928355
- ENUM-LEGACY 2006
- TAX-NARROW 571
- RX-MID 1,589
- BOOK-THIN 9 in Georgia
- PHOTO-ENUM Catherine Best, MD · 2006
Daniel Gaskin, Jr., M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
1,589 ≥ 81st percentile 81% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Daniel Gaskin, Jr., M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Daniel Gaskin, Jr., M.D.?
Quality data not reportedPrimary specialty
Addiction Medicine (Internal Medicine) Physician
Medicare Part D claims
1,589 9% vs specialty avg
Specialty distribution in Georgia
How Addiction Medicine (Internal Medicine) Physician compares to other specialties among Georgia providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Addiction Medicine (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1205928355 |
|---|---|
| Specialty | Addiction Medicine (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/28/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Daniel Gaskin, Jr., M.D.. Source: openpaymentsdata.cms.gov.
Total received
$38
Largest payer
Inspire Medical Systems, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
Daniel Gaskin, Jr., M.D. - brand share 6.0%
Addiction Medicine (Internal Medicine) Physician average
6% brand-name claims vs 94% generic, on 1,589 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,589
Total Claims
$147K
Total Drug Cost
118
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,853.067
- Total Day Supply
- 51,448
- Brand vs Generic
- 6% brand / 94% generic
- Brand Drug Cost
- $52K
- Generic Drug Cost
- $95K
- Opioid Claims
- 45 (2.8% rate)
Patient Demographics
- Average Patient Age
- 66.6 years
- Avg HCC Risk Score
- 1.50
- Gender Split
- 56% female / 44% male
- Age Distribution
- <65: 39, 65-74: 53, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Daniel Gaskin, Jr., M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Buprenorphine-Nalo…
Buprenorphine-Naloxone
607 claims
- Buprenorphine Hcl 152
Buprenorphine Hcl
152 claims
- Gabapentin 117
Gabapentin
117 claims
- Quetiapine Fumarate 92
Quetiapine Fumarate
92 claims
- Trazodone Hcl 81
Trazodone Hcl
81 claims
- Zubsolv 67
Zubsolv
67 claims
- Tizanidine Hcl 61
Tizanidine Hcl
61 claims
- Hydroxyzine Pamoate 46
Hydroxyzine Pamoate
46 claims
| Drug | Claims |
|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 607 |
| Buprenorphine Hcl | 152 |
| Gabapentin | 117 |
| Quetiapine Fumarate | 92 |
| Trazodone Hcl | 81 |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | 67 |
| Tizanidine Hcl | 61 |
| Hydroxyzine Pamoate | 46 |
| Pregabalin | 32 |
| Oxcarbazepine | 26 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Addiction Medicine (Internal Medicine) Physician in GA →
All providers in Georgia →
Compare specialties →
Addiction Medicine (Internal Medicine) Physician Overview
How Daniel Gaskin, Jr., M.D. fits within the Addiction Medicine (Internal Medicine) Physician landscape nationally.
571
Addiction Medicine (Internal Medicine) Physician Providers in US
46
States with Addiction Medicine (Internal Medicine) Physician
1,455
Avg Claims per Provider
Daniel Gaskin, Jr., M.D.'s 1,589 claims are above the specialty average of 1,455.
Nationwide Addiction Medicine (Internal Medicine) Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Gaskin, Jr., both outside Georgia so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Addiction Medicine (Internal Medicine) Physician Providers in Georgia
Other clinicians with the same primary specialty enrolled in Georgia, drawn from the same CMS NPPES roster as Gaskin, Jr..
One of 9 Addiction Medicine (Internal Medicine) Physician providers enrolled in Georgia, 5 are shown here.
Frequently Asked Questions
What is Daniel Gaskin, Jr., M.D.'s specialty? ▼
Daniel Gaskin, Jr., M.D. specializes in Addiction Medicine (Internal Medicine) Physician and practices in Savannah, Georgia. Credentials: M.D..
How much does Daniel Gaskin, Jr., M.D. prescribe under Medicare Part D? ▼
In 2024, Daniel Gaskin, Jr., M.D. wrote 1,589 Medicare Part D claims totaling $147K in drug costs for 118 beneficiaries.
Where is Daniel Gaskin, Jr., M.D. located? ▼
Daniel Gaskin, Jr., M.D. is located at 315 COMMERCIAL DR, Savannah, GA, 31406. Phone: (912) 352-9902.
What is Daniel Gaskin, Jr., M.D.'s NPI number? ▼
Daniel Gaskin, Jr., M.D.'s National Provider Identifier (NPI) is 1205928355, issued on 09/28/2006.
Does Daniel Gaskin, Jr., M.D. prescribe more brand-name or generic drugs? ▼
Daniel Gaskin, Jr., M.D.'s prescribing is 6% brand-name and 94% generic drugs by claim count, with $52K in brand drug costs.
Does Daniel Gaskin, Jr., M.D. prescribe opioids? ▼
Yes, Daniel Gaskin, Jr., M.D. had 45 opioid claims in 2024 with an opioid prescribing rate of 2.8%.
How many Addiction Medicine (Internal Medicine) Physician providers are there in the US? ▼
There are 571 Addiction Medicine (Internal Medicine) Physician providers across 46 states in the US. The average Addiction Medicine (Internal Medicine) Physician provider writes 1,455 Medicare Part D claims per year.
What drugs does Daniel Gaskin, Jr., M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Daniel Gaskin, Jr., M.D.'s most frequently prescribed drugs include Buprenorphine-Naloxone, Buprenorphine Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Daniel Gaskin, Jr., M.D. accept Medicare? ▼
Daniel Gaskin, Jr., M.D. appears in CMS Medicare data with 1,589 Part D claims and 118 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Daniel Gaskin, Jr., M.D.'s credentials? ▼
Daniel Gaskin, Jr., M.D.'s NPI is 1205928355 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.